Clinical Trials

2,000 enrolled

Breast Neoplasms

NCT01553903 2026-04-14

OXYTAM

29 enrolled

Breast Neoplasms

NCT01612871 2026-04-14

MIRHO

39 enrolled

Breast Neoplasms

NCT00893061 2026-03-17

MNEMOSYNE

44 enrolled

Breast Neoplasms

NCT02767661 2026-02-27

MECCA

263 enrolled

Breast Neoplasms

NCT03079011 2025-11-18

PADA-1

1,017 enrolled

Breast Neoplasms

NCT03909152 2025-07-28

A Study of Onapristone ER Alone Or In Combination With Anastrozole in Gynecologic Cancers That Respond to Progesterone

34 enrolled 9 charts

Gynecologic

Granulosa Cell Ovarian Cancer

NCT05635357 2025-07-28

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Anastrozole vs Exemestane/Letrozole

16,989 enrolled

Breast Neoplasms

NCT00253422 2025-06-04

SoFEA

698 enrolled 19 charts

Breast Neoplasms

NCT03554044 2025-05-21

T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer

Phase 1 Completed

20 enrolled

Breast Neoplasms

NCT02040857 2025-04-29

Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer

162 enrolled 12 charts

Breast Neoplasms

NCT03219476 2025-04-29

Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer

37 enrolled 10 charts

Breast Neoplasms

NCT00265759 2025-04-23

Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer

622 enrolled 18 charts

Breast Neoplasms

NCT02206984 2025-03-11

Endocrine Response in Women With Invasive Lobular Breast Cancer

201 enrolled

Breast Neoplasms

NCT03691493 2025-02-17

ASPIRE

36 enrolled 17 charts

Breast Neoplasms

NCT04294225 2025-01-28

Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer

161 enrolled 12 charts

Breast Neoplasms

NCT01216176 2025-01-08

A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer

Phase 1/2 Completed

71 enrolled 15 charts

Breast Neoplasms

NCT00072462 2024-09-19

IBIS-II DCIS

2,980 enrolled 14 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT02188745 2024-07-17

POLLY

19 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT02648477 2024-03-19

Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer

30 enrolled 11 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01814397 2024-02-07

Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer Patients

50 enrolled 15 charts

Breast Neoplasms, Pain, Arthralgia

NCT00719966 2024-01-02

Effect of Aromatase Inhibitor Therapy on Blood Vessel Function in Postmenopausal Women With Breast Cancer

109 enrolled

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT03555877 2023-07-07

AMICA

56 enrolled

Breast Cancer Metastatic

NCT00921115 2023-05-19

Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.

42 enrolled 5 charts

Breast Neoplasms

NCT00128843 2023-03-06

Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients

103 enrolled

Breast Neoplasms

NCT00301457 2023-02-21

DATA

1,914 enrolled

Breast Neoplasms

NCT02440230 2022-12-30

SEAT

110 enrolled

Breast Neoplasms

NCT03948568 2022-09-30

REaCT-RETT

262 enrolled

Breast Neoplasms

NCT01791985 2022-08-22

RADICAL

Phase 1/2 Completed

52 enrolled 17 charts

Breast Neoplasms

NCT01989780 2022-08-04

BOOSTER

160 enrolled

Breast Neoplasms

NCT00405938 2021-11-18

Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer

79 enrolled 7 charts

Breast Neoplasms

NCT00078832 2021-10-06

IBIS II

3,864 enrolled

Breast Neoplasms

NCT03768258 2021-09-05

TIBCaP

1,268 enrolled

Breast Neoplasms

NCT00629616 2021-06-09

NIMFEA

116 enrolled

Breast Neoplasms

NCT00256217 2021-05-11

Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women

42 enrolled 10 charts

Carcinoma, Intraductal, Noninfiltrating

NCT00871858 2021-02-24

HORGEN

120 enrolled 11 charts

Breast Neoplasms

NCT01197170 2021-01-22

Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance

Phase 1 Completed

277 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT01004744 2021-01-11

Pre-Surgical Intervention for Targeted Therapies for Breast Cancer

10 enrolled 4 charts

Invasive Breast Cancer

NCT02511639 2020-12-03

MAIN-A

110 enrolled

Breast Cancer Metastatic

NCT00570323 2020-07-28

PACT001

72 enrolled 8 charts

Breast Neoplasms

NCT02291913 2020-02-17

Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer

48 enrolled 13 charts

Breast Neoplasms

NCT04258163 2020-02-10

Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy

760 enrolled

Breast Neoplasms

NCT01720602 2020-01-07

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy

15 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00240071 2019-10-30

Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.

30 enrolled 7 charts

Breast Neoplasms

NCT00186121 2019-10-07

Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women

35 enrolled 11 charts

Breast Neoplasms

NCT01153672 2019-09-06

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy

8 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00179517 2019-07-17

Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo

40 enrolled 13 charts

EndocrineOther

Epilepsy, Hypogonadism, Erectile Dysfunction, Seizures, Sexual Dysfunction, Physiological, Multiple Endocrine Neoplasia Type 1

NCT00111241 2018-12-14

Changes in Knee Articular Cartilage Volume in Women on Aromatase Inhibitors

115 enrolled 6 charts

Breast Neoplasms, Osteoporosis, Arthralgia, Fractures, Bone

NCT00612560 2017-10-12

FABrC

28 enrolled 14 charts